Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can beetroot juice boost brain and body function in kidney patients?

NCT ID NCT03826147

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether drinking nitrate-rich beetroot juice every day for three months can improve blood vessel health, movement, and thinking in people with chronic kidney disease. About 92 participants with moderate kidney disease will receive either the active beetroot juice or a placebo version. The goal is to see if this simple supplement can help prevent disability and other health problems.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
nitrate-rich beetroot juice
What this could lead to
If it works, this could point toward a simple dietary supplement to help preserve physical and mental function in chronic kidney disease.
What could go wrong
This is a small, early-phase study with only 92 participants, and the benefits may not be large or apply to everyone. Beetroot juice is generally safe but may cause stomach upset or low blood pressure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

About 92 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2019

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * CKD stage II-IV (eGFR using the Modification of Diet in Renal Disease (MDRD) prediction equation 20-90 mL/min/1.73m2; stable renal function in the past 3 months) * Ability to give informed consent * Albumin \> 3.0 g/dL * Ability to perform motor and cognitive tests (e.g., can rise from a chair, walk for 6 min, climb 10 stairs) * Free from alcohol dependence or abuse, as defined by the American Psychiatry Association, Diagnostic and Statistical Manual of Mental Disorders (DSM-V) * Mini-mental state examination score \>21 (rationale: to screen for subjects with major cognitive impairment) * Blood pressure (BP) \>100/60 mmHg for past 3 months (rationale: blood pressure below 100/60 mmHg may elevate the normally small risk of hypotension with nitrate supplementation) * Not taking medications that will interfere with administered medications (e.g., sildenafil interacts with nitroglycerin) * Body mass index (BMI) \<40 kg/m2 (vascular function measurements can be inaccurate in severely obese patients) Exclusion Criteria: * Life expectancy \<1 year * Uncontrolled hypertension, defined as blood pressure \> 160/100 mmHg in the past 3 months * History of severe liver disease * History of severe congestive heart failure (i.e., ejection fraction \< 35%) * History of hospitalizations within the last 3 months * Active infection or antibiotic therapy * Warfarin use * Vasculitis requiring immunosuppressive therapy within the last year * High dietary nitrate intake or current nitrate/nitrite supplementation; hypersensitivity to nitrates or nitrites * Glucose-6-phosphate dehydrogenase deficiency or blood methemoglobin \>2% * Unwilling to abstain from use of mouthwash or other oral hygiene practices (e.g., tongue scraping) outside of teeth brushing that disrupt the oral microbiome and would interfere with nitrate conversion to nitrite * Blood donation within 8 weeks prior to enrolling in the study; unwilling to abstain from donating blood for 8 weeks after completing the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic kidney disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Integrative Physiology of Aging Laboratory

    Boulder, Colorado, 80309, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.